1. Home
  2. Live Updates
  3. Vesalius biocapital

Live Breaking News & Updates on Vesalius biocapital

Stay informed with the latest breaking news from Vesalius biocapital on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vesalius biocapital and stay connected to the pulse of your community

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30,...
-Today at 04:06 pm- MarketScreener

Alabama , United-states , Paris , France-general- , France , America , American , Jean-christophe-renondin , Michaeld-west , Juvenescence-limited , Serina-therapeutics-inc , Linkedin

Meet the VC: Vesalius Biocapital

In our “meet the VC” series, Delano is talking to local venture capitalists to discover their firms and their perspectives on the field. In this edition, Fabienne Roussel introduces us to Vesalius Biocapital and discusses healthtech in Luxembourg.

Portugal , Luxembourg , Lisbon , Lisboa , Paris , France-general- , France , Finland , Germany , Belgium , Amsterdam , Noord-holland

Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million

/PRNewswire/ -- Vesalius Biocapital, the specialist life sciences venture capital investor, announces the first close of its fourth fund, Vesalius Biocapital...

Luxembourg , Strassen , United-states , China , American , Chinese , David-cristina , Worg-pharma , Astellas-pharma , Stephane-heymans , Fabienne-roussel , Marjut-falkstedt

Vesalius Biocapital Holds First Close of Fourth Fund Raising EUR 95M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

China , Luxembourg , Chinese , Jean-christophe-renondin , Worg-pharma , David-cristina , Qasim-zawawi , Fabienne-roussel , Stephane-heymans , Astellas-pharma , Olivier-houben , Sword-health

Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer

Building on positive clinical data from Topas' Phase 1 study of TPM203 in pemphigus vulgaris patients, the Phase 2a study in celiac disease patients initiates clinical development for TPM502 and

Cristina-de , Galicia , Spain , Germany , Barcelona , Comunidad-autonoma-de-cataluna , Hamburg , Christian-schr , Gewinn-nur , Erichf-greiner , Priscillia-perrin , Merck-group

Australian venture capital fund joins partners in backing new immunotherapy

Australian venture capital fund joins partners in backing new immunotherapy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Andreas-wallnoefer , Jonathan-tobin , Phil-lhuillier , Bayern-kapital , Novartis-venture-fund , Brandon-capital , Jeito-capital , Vesalius-biocapital , Biogeneration-ventures , Growth-differentiation ,

Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer

Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for

Germany , United-states , Paris , France-general- , France , Denmark , Munich , Bayern , United-kingdom , Belgium , Switzerland , German

CatalYm Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors

CatalYmtoday announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation

Australia , United-states , Paris , France-general- , France , United-kingdom , Bayern-kapital , Sue-charles , Ciara-byrne , Catalym-gmb , Kostenloser-wertpapierhandel , Andreas-wallnoefer

CatalYm Closes EUR 50M Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Germany , Munich , Bayern , Andreas-wallnoefer , Jonathan-tobin , Phil-lhuillier , Bayern-kapital , Novartis-venture-fund , Brandon-capital , Jeito-capital , Vesalius-biocapital , Biogeneration-ventures

Study Leveraging DEARhealth Care Management Platform for Ovarian Cancer Care Launched

Los Angeles, California (PRWEB) October 24, 2022 -- Collaborative study supported by GSK to assess potential improvement to standard of care will be led by

California , United-states , Los-angeles , Pratibha-binder , Tiffany-lai , Joshuag-cohen , Hui-amy-chen , Shannon-altimari , Daniel-hommes , University-of-california , Dearhealth-inc , David-geffen-school-of-medicine